Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1990 May;83(5):308–311. doi: 10.1177/014107689008300510

Lymphoproliferative responses in recrudescent orofacial herpetic infections.

J P Vestey 1, M Norval 1, S E Howie 1
PMCID: PMC1292650  PMID: 2166159

Abstract

The relationship between antibody (Ab) and lympho-proliferative responses to herpes simplex virus (HSV) and recrudescent orofacial HSV lesions were investigated in 65 patients. All had HSV-specific Ab and cell mediated immune responses (CMIR) demonstrated by ELISA and in vitro lymphoproliferation respectively. Thirteen control subjects were negative in both tests. Thirty-three patients were repeatedly investigated for 6-38 months during which time they suffered 1-8 recrudescences. HSV-induced lymphoproliferation was depressed during recrudescences, rose to a peak several weeks later, and declined slowly to a background level. However, ELISA titres and lymphoproliferative responses to Concanavalin A (Con A) were high throughout and circulating peripheral blood mononuclear cell (PBMC) subsets did not change. Depressed lymphoproliferative responses to HSV antigen (Ag) during recrudescences were enhanced by removal of CD8+ cells from PBMC using either a panning technique or cell sorting; reconstitution of CD8+ cells suppressed the HSV-specific lymphoproliferative response. CD8+ cell depletion affected neither HSV-induced lymphoproliferation recrudescence, nor lymphoproliferative responses to another Ag (PPD) during recrudescence. Depressed HSV-induced lymphoproliferation during recrudescences might thus be due to CD8+ suppressor T cell (Ts) function rather than low numbers of circulating lymphocytes. Suppression or delay of normal CMIR to asymptomatic recurrent epidermal HSV infection by Ts might allow development of recrudescent HSV lesions.

Full text

PDF
308

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cauda R., Laghi V., Tumbarello M., Ortona L., Whitley R. J. Immunological alterations associated with recurrent herpes simplex genitalis. Clin Immunol Immunopathol. 1989 May;51(2):294–302. doi: 10.1016/0090-1229(89)90027-5. [DOI] [PubMed] [Google Scholar]
  2. Corey L., Reeves W. C., Holmes K. K. Cellular immune response in genital herpes simplex virus infection. N Engl J Med. 1978 Nov 2;299(18):986–991. doi: 10.1056/NEJM197811022991805. [DOI] [PubMed] [Google Scholar]
  3. Corey L., Spear P. G. Infections with herpes simplex viruses (1). N Engl J Med. 1986 Mar 13;314(11):686–691. doi: 10.1056/NEJM198603133141105. [DOI] [PubMed] [Google Scholar]
  4. El Araby I. I., Chernesky M. A., Rawls W. E., Dent P. B. Depressed herpes simplex virus-induced lymphocyte blastogenesis in individuals with severe recurrent herpes infections. Clin Immunol Immunopathol. 1978 Feb;9(2):253–263. doi: 10.1016/0090-1229(78)90078-8. [DOI] [PubMed] [Google Scholar]
  5. Kalimo K. O., Joronen I. A., Havu V. K. Cell-mediated immunity against herpes simplex virus envelope, capsid, excreted, and crude antigens. Infect Immun. 1983 Jan;39(1):24–28. doi: 10.1128/iai.39.1.24-28.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Rüdlinger R., Norval M. Herpes simplex virus infections: new concepts in an old disease. Dermatologica. 1989;178(1):1–5. doi: 10.1159/000248375. [DOI] [PubMed] [Google Scholar]
  7. Sheridan J. F., Beck M., Aurelian L., Radowsky M. Immunity to herpes simplex virus: virus reactivation modulates lymphokine activity. J Infect Dis. 1985 Sep;152(3):449–456. doi: 10.1093/infdis/152.3.449. [DOI] [PubMed] [Google Scholar]
  8. Sheridan J. F., Beck M., Smith C. C., Aurelian L. Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitro. J Immunol. 1987 Feb 15;138(4):1234–1239. [PubMed] [Google Scholar]
  9. Sheridan J. F., Donnenberg A. D., Aurelian L., Elpern D. J. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets. J Immunol. 1982 Jul;129(1):326–331. [PubMed] [Google Scholar]
  10. Tsutsumi H., Bernstein J. M., Riepenhoff-Talty M., Cohen E., Orsini F., Ogra P. L. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses. Clin Exp Immunol. 1986 Dec;66(3):507–515. [PMC free article] [PubMed] [Google Scholar]
  11. Vestey J. P., Howie S. E., Norval M., Maingay J. P., Neill W. A. Immune responses to herpes simplex virus in patients with facial herpes simplex and those with eczema herpeticum. Br J Dermatol. 1988 Jun;118(6):775–782. doi: 10.1111/j.1365-2133.1988.tb02595.x. [DOI] [PubMed] [Google Scholar]
  12. Vestey J. P., Norval M., Howie S., Maingay J., Neill W. A. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections. Clin Exp Immunol. 1989 Sep;77(3):384–390. [PMC free article] [PubMed] [Google Scholar]
  13. Wainberg M. A., Portnoy J. D., Clecner B., Hubschman S., Lagacé-Simard J., Rabinovitch N., Remer Z., Mendelson J. Viral inhibition of lymphocyte proliferative responsiveness in patients suffering from recurrent lesions caused by herpes simplex virus. J Infect Dis. 1985 Sep;152(3):441–448. doi: 10.1093/infdis/152.3.441. [DOI] [PubMed] [Google Scholar]
  14. Wildy P., Gell P. G. The host response to herpes simplex virus. Br Med Bull. 1985 Jan;41(1):86–91. doi: 10.1093/oxfordjournals.bmb.a072032. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES